Israel
Identifai Genetics is a Health Care startup founded in 2021 and based in Israel. The company's slogan, "Revolutionizing prenatal diagnosis," encapsulates its mission to transform prenatal testing. Utilizing a non-invasive approach, Identifai Genetics offers a groundbreaking alternative to traditional, risky methods such as amniocentesis. With a simple blood test from the mother-to-be, the startup can read the fetal DNA, eliminating the need for invasive and late testing procedures.
In the latest funding round, eHealth Ventures and Ron Sabar invested $3.30M in Identifai Genetics, signaling investor confidence in the company's innovative approach to prenatal diagnosis. This significant investment will likely bolster the startup's R&D efforts and further its mission to revolutionize prenatal testing.
